CytoMed Therapeutics Ltd (GDTC) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$324.4K

Net Income/Loss (FY2025)

-$3.1M

Total Assets (FY2025)

SGD 6.2M

Total Equity (FY2025)

SGD 5.3M

Cash Flows from Operating Activities (FY2025)

-$3.7M

Source: CytoMed Therapeutics Ltd 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.